KilgourMD Secures Series A Funding to Transform Scalp Health and Hair Regrowth Solutions

KilgourMD's Significant Breakthrough in Hair Regrowth Funding

Introduction

KilgourMD, a pioneering brand founded by board-certified dermatologist Dr. James Kilgour, has recently closed a Series A funding round aimed at revolutionizing scalp health and hair regrowth. This funding is spearheaded by Prelude Growth Partners, with participation from existing backers such as Willow Growth, Joyance Partners, and Able Partners. Established in 2023, KilgourMD has swiftly gained traction in the dermatological field by addressing a common, yet often stigmatized, issue: hair loss.

Background of KilgourMD

Inspired by his mother’s struggles with hair loss during menopause, Dr. Kilgour founded KilgourMD to create effective and clinically-proven solutions for hair thinning. In a world where hair loss can often affect self-esteem and quality of life, KilgourMD stands out by utilizing scientific research and dermatological expertise to formulate products that truly work.

Funding Details

The recent Series A funding signifies more than just financial backing; it epitomizes a shared vision between KilgourMD and Prelude Growth Partners. Alicia Sontag, Managing Partner at Prelude, expressed excitement about the differentiation and clinical grounding of KilgourMD’s approach. With these funds, KilgourMD plans to expand its innovative product pipeline and conduct additional clinical trials focused on underserved populations experiencing hair loss.

Clinical Trials and Results

KilgourMD boasts of a successful profitable year in 2025 and has completed its inaugural clinical trial concentrated on menopausal women utilizing its unique two-step scalp serum system. The results were compelling, revealing that 95% of participants experienced less hair shedding within six weeks, with the majority achieving notable hair regrowth after four months. These outcomes have been submitted for publication in the Journal of Drugs in Dermatology, underscoring the brand's commitment to evidence-based approaches to hair loss solutions.

Moving Forward

With the Series A funding, KilgourMD aims to advance its proprietary active ingredient pipeline and further refine its product lineup. By continuing to focus on the intricacies of scalp health—often overlooked in traditional hair care—the brand seeks to redefine how consumers think about hair loss and prevention.

Building a Community

KilgourMD is also dedicated to fostering a community among its customers, normalizing conversations surrounding hair loss and scalp health. This strategy has proven effective: more than 33% of customers have recommended KilgourMD’s products to friends and family. This shared experience helps to de-stigmatize hair loss and creates a sense of community among users facing similar challenges.

Conclusion

As KilgourMD strides towards a more robust and innovative future, the brand is not only focusing on product development but also on creating meaningful connections with its growing customer base. This combination of clinical research, community building, and innovative products positions KilgourMD as a trailblazer in the hair care industry, poised to maintain its momentum in the coming years.

About the Company

KilgourMD is a trailblazing brand committed to redefining hair care through a keen focus on scalp health. Founded by Dr. James Kilgour, the company offers clinically verified solutions that cater to diverse hair types and genders. Positioned at the nexus of dermatology and consumer wellness, KilgourMD aspires to set new standards in the industry.

About Prelude Growth Partners

Prelude Growth Partners is a prominent growth equity firm headquartered in New York. The firm specializes in partnering with innovative consumer brands, thereby providing operational support, industry expertise, and extensive networking opportunities to foster growth in high-potential companies across various sectors, including health and wellness, beauty, and consumer services.